Loading
A phase 1 trial of ACTM-838 run by Actym Therapeutics, Inc., terminated.
A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors is a phase 1 interventional study registered as NCT06336148 by Actym Therapeutics, Inc., with 10 participants enrolled, started 2024-06-05. Conditions recorded: Solid Tumor. Interventions recorded: ACTM-838.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/